Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Generay Biotech Co., Ltd. (Generay Biotechnology) is a professional biotechnology company and contract research and manufacturing organization (CRO/CMO) founded in 2002 and headquartered in Shanghai, China. The company specializes in DNA synthesis, RNA synthesis, gene synthesis, DNA sequencing, and the manufacture of molecular biology kits and PCR-related reagents. Generay provides high-quality customized services and research products to over 100,000 scientists and molecular diagnostics (IVD) industry partners worldwide. Its core offerings include Taqman probes, molecular beacons, shRNA/siRNA/miRNA synthesis, and gene editing tools like sgRNA design and CRISPR/Cas9 plasmid construction. Additionally, Generay operates five synthetic bases across China to ensure rapid delivery and has achieved ISO 9001 and ISO 13485 certifications for its quality management systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Generay Biotechnology.